Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 128,356 | 127,571 | 125,966 | 120,898 | 115,300 |
| Cost of Goods | 101,528 | 99,816 | 98,930 | 97,957 | 96,952 |
| Gross Profit | 26,828 | 27,755 | 27,036 | 22,941 | 18,348 |
| Operating Expenses | 20,875 | 12,953 | 13,321 | 12,246 | 19,691 |
| Operating Income | 6,481 | 15,618 | 14,645 | 11,652 | -391 |
| Interest Expense | 3,429 | 3,081 | 3,138 | 2,707 | 2,644 |
| Pre-tax Income | 3,052 | 12,537 | 11,507 | 8,945 | -3,035 |
| Income Tax | 610 | 5,847 | 3,856 | 1,789 | -1,196 |
| Net Income Continuous | 2,442 | 6,690 | 7,651 | 7,156 | -1,839 |
| Minority Interests | 69 | -61 | 127 | 90 | 49 |
| Net Income | $2,373 | $6,751 | $7,524 | $7,066 | $-1,888 |
| EPS Basic Total Ops | 0.05 | 0.15 | 0.16 | 0.15 | -0.04 |
| EPS Basic Continuous Ops | 0.05 | 0.14 | 0.17 | 0.15 | -0.04 |
| EPS Diluted Total Ops | 0.05 | 0.15 | 0.16 | 0.15 | -0.04 |
| EPS Diluted Continuous Ops | 0.05 | 0.15 | 0.16 | 0.15 | -0.04 |
| EBITDA(a) | $10,525 | $19,691 | $18,816 | $16,012 | $4,166 |